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Methylene Blue for MDI 
To the Editor: 
The correspondence from Drs. Thomas and Callender 
(1985) regarding use of methylene blue in treatment 
of bipolar illness is of particular interest to me. In 
1946, I wondered whether schizophrenia might be 
related to disturbance in redox potentials within neu- 
rons, a disturbance possibly correctable by oral 
administration of methylene blue. I wrote to Ralph 
W. Gerard, who responded that he had tried it without 
success and that another dye, which he named but I 
have forgotten, with a higher E~o, might be useful. 
While I waited for Gerard's letter, I obtained per- 
mission from the VA (Dr. Daniel Blain) to try meth- 
ylene blue 100 rag, t.i.d. Six psychiatric residents at 
the Northport facility each ordered the trial for 2 
weeks on a patient of each. No patient exhibited a 
favorable change. I must add that if further trial of 
methylene blue is contemplated, the product must be 
free of arsenic, an impurity usually present in con- 
sequence of synthesis of the dye. 
William J. Turner 
January 4, 1985 
Department of Psychiatry and Behavioral Science 
State University of New York 
Stony Brook, NY 11794 
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Sleep-Onset REM Period in Paranoid 
Schizophrenia 
To the Editor: 
A pathological sleep-onset rapid eye movement pe- 
riod (SOREMP) has been defined as any REM period 
occurring immediately after or within 15 min of the 
onset of sleep (Dement 1976). It has been reported 
in a number of conditions---narcolepsy (Dement 1976), 
primary depression (Patricia Koble et al. 1981), psy- 
chotic depression (Kupfer and Foster 1975), am- 
phetamine withdrawal, disturbances of the sleep--wake 
cycle, and occasionally in normal individuals. There 
have been no reports of SOREMP in schizophrenia. 
We report a case of SOREMP in chronic paranoid 
schizophrenia; the patient was a nonresponder to 
treatment, and interestingly, the SOREMP persisted 
after treatment. 
The patient was a 37-year-old black male who 
was admitted to the Clinical Studies Unit for Affec- 
tive Disorders at the University of Michigan, after 
complaining of hearing voices of people he had known 
several years ago, a belief that objects from the en- 
vironment were being incorporated into his body, and 
difficulty in concentrating. He further exhibited pas- 
sive somatic delusions, thought insertion, and per- 
secutory delusions. These symptoms had persisted 
for 3 years, and his highest level of adaptive func- 
tioning over the last 12 months was poor. He was 
diagnosed by several clinicians independently, using 
RDC/SADS and the DMS-III, as having chronic par- 
anoid schizophrenia. His Brief Psychiatric Rating Scale 
(BPRS) score was consistently above 40, and he did 
not have any of the major symptoms and signs of 
depression. Furthermore, there were no clinical fea- 
tures indicative of narcolepsy (sleep attacks, cata- 
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plexy, sleep paralysis, or hypnagogic hallucinations), 
no apparent disturbance of his sleep--wakefulness cycle, 
and no jet lag. His physical exam and laboratory 
studies, which included (1) CBC, differential, (2) 
serum electrolytes, thyroid studies, B12 and folate, 
(3) head CT, and (4) EEG with nasopharyngeal leads, 
were unremarkable. The patient underwent the 2- 
week drug-free washout period prior to his first sleep 
electroencephalogram (EEG) recording. The elec- 
trode placement and scoring were done according to 
the criteria established by Rechtschaffen and Kales 
(1968). 
Sleep data obtained on the first and second nights 
of recording (pre-ECT) revealed zero REM latency 
on both nights (see Table 1). The patient was treated 
with thiothixene (40 rag/day) for over 3 weeks, fol- 
lowed by trifluoperazine (60 mg/day) for an adequate 
period of time. No clinical response was observed, 
and we consequently broke the research code for sleep 
EEG. The SOREMP was noted, and the prospect of 
delusional depression, though deemed unlikely, was 
entertained. A combination of trifluoperazine and de- 
sipramine (blood level of 208 ng/ml) for an adequate 
period of time, followed by a complete course of 
electroconvulsive therapy (ECT) (nine shock treat- 
ments), failed to bring about any significant clinical 
improvement (his BPRS score remained above 40). 
Sleep EEGs were repeated for 2 nights, 14 days after 
the last ECT, and the REM latency remained zero on 
both nights. A Multiple Sleep Latency Test (MSLT) 
was not performed, as the patient did not have any 
clinical features suggestive of narcolepsy. 
Sleep-onset REM has not been reported in schizo- 
phrenia, though a variety of other REM irregularities 
have been noted. Some investigators (Jus et al. 1973) 
consider a decrease in REM latency to be one of the 
most consistent sleep pattern alterations in schizo- 
phrenia. It has also been suggested that a shortened 
REM latency in schizophrenia identifies a subgroup 
that require antidepressant treatment. Our patient nei- 
ther had any clinical evidence of depression, nor did 
he respond to any of the therapeutic interventions. 
The occurrence of persistent SOREMP in our patient 
may represent a distinct undefined pathophysiological 
process. We would like to suggest that SOREMP may 
occur in schizophrenia, as well as in other patho- 
physiological states for which it has been described, 
and furthermore, that this sleep EEG finding may 
indicate a poor treatment response. This question will 
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Table 1. 
HRSD REM 
Nights of sleep recording scores latency 
Duration of first 
REM period in REM Percent 
minutes density REM sleep 
Day 1 (pre-ECT) 9 0 
Day 2 (pre-ECT) 9 0 
Day 3 (14 days post-ECT) 3 0 
Day 4 (15 days post-ECT) 3 0 
8 1.1480 19.014 
7 1.9320 24.104 
3 1.3000 26.596 
10 1.5780 19.453 
